GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
Category:Team N terminals
|Status||Page||User||Date/Time||GO Term (Aspect)||Reference||Evidence||Notes||Links|
|SYNY3:FTSH2||Freezen, Team N terminals||2014-03-02 20:53:43 CST||GO:0042651 thylakoid membrane (C)||PMID:16286465||ECO:0000314 direct assay evidence used in manual assertion|
|BVDV:A0N0F0||Albdan, Team N terminals||2014-03-02 01:44:27 CST||GO:0043066 negative regulation of apoptotic process (P)||PMID:24551175||ECO:0000315 mutant phenotype evidence used in manual assertion|
Inhibition of apoptosis by Npro correlates with degradation of IRF3 in fig 1.
|YEAST:IF2A||Albdan, Team N terminals||2014-03-01 11:48:21 CST||GO:0039585 PKR signal transduction (P)||PMID:24338483||ECO:0000315 mutant phenotype evidence used in manual assertion|
Protein kinase R (PKR) dimerization and activation loop autophosphorylation are mutually exclusive yet interdependent process. in fig 4.
|?||Albdan, Team N terminals||2014-02-27 18:32:03 CST||GO:0010628 positive regulation of gene expression (AMPK promotes DAF-16 activity, implies metabolic regulators in a positive feedback loop that accelerates the induction of DAF-16 target gene expression. from fig 5.)||PMID:24516399||IDA: Inferred from Direct Assay||challenge|
|HUMAN:GDF8||Freezen, Team N terminals||2014-02-27 10:27:06 CST||GO:0042787 protein ubiquitination involved in ubiquitin-dependent protein catabolic process (P)||PMID:24451368||ECO:0000314 direct assay evidence used in manual assertion|
Results shown in Figure 8 and process is diagrammed in Figure 9.
|BVDV:A0N0F0||Albdan, Team N terminals||2014-02-27 01:17:20 CST||GO:0043653 mitochondrial fragmentation involved in apoptotic process (P)||PMID:24551175||ECO:0000315 mutant phenotype evidence used in manual assertion|
the Npro protein prevent fragmentation of mitochondria to inhibit apoptosis in response to cell stress in fig 2.